Develop an innovative computational platform to analyze data from spatial metabolomics for use in drug development

Ended Cooperative Agreement Awarded Last action

Award ID
70NANB23H244
Recipient
Awarding agency
Obligated
$200,000

Award facts

Completion date
Originally
Place of performance
San Antonio, TX 78229, USA

Award details come from USAspending.gov.

Description

Purpose
The purpose of this grant is to develop an innovative computational platform to analyze data from spatial metabolomics for use in drug development.
Activities
Establish calibration standards; develop a computational platform, validation of research activities.
Expected outcomes
The phase I project will assess the technical viability of the recipients computational model and support phase II research and development of its technology.
Intended beneficiaries
Health, medical and pharmaceutical industries.
Subrecipient activities
The recipient plans to subaward funds for project direction, and to conduct metabolic measurement activities.

Transactions

Action Obligated Date
Amendment $0
Amendment $100,000
Original award $100,000

Quick answers

Who received award 70NANB23H244?

70NANB23H244 was awarded to Sygnamap Inc. by National Institute of Standards and Technology (Department of Commerce) on October 1, 2023.

How much is award 70NANB23H244 worth?

$200,000 has been obligated on 70NANB23H244.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award